FRANCISCO
MARTÍN MOLINA
CONTRATO MARÍA ZAMBRANO SENIOR
Publications (163) Publications de FRANCISCO MARTÍN MOLINA
2024
-
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas
Molecular Therapy Nucleic Acids, Vol. 35, Núm. 4
-
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
Frontiers in Immunology, Vol. 15
-
NLRP3 and AIM2 inflammasomes expression is modified by LPS and titanium ions increasing the release of active IL-1β in alveolar bone-derived MSCs
Stem Cells Translational Medicine, Vol. 13, Núm. 8, pp. 826-841
2023
-
LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis
International Journal of Molecular Sciences, Vol. 24, Núm. 13
-
Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C
Molecular Therapy - Nucleic Acids, Vol. 33, pp. 75-92
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
Reductive carboxylation epigenetically instructs T cell differentiation
Nature, Vol. 621, Núm. 7980, pp. 849-856
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
Frontiers in Immunology
-
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
Frontiers in Immunology, Vol. 13
-
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))
Molecular Therapy - Oncolytics
-
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies
International Journal of Molecular Sciences, Vol. 23, Núm. 11
-
Physiological lentiviral vectors for the generation of improved CAR-T cells
Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349
2021
-
Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells
Biomacromolecules, Vol. 22, Núm. 4, pp. 1374-1388
-
Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells
Frontiers in Genome Editing, Vol. 3
-
Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases
Cancers, Vol. 13, Núm. 1, pp. 1-45
-
Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks
Pharmaceutics, Vol. 13, Núm. 8
-
LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy
RNA Biology, Vol. 18, Núm. S1, pp. 198-214
2020
-
Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism
Human Molecular Genetics, Vol. 29, Núm. 19, pp. 3296-3311